Low doses of etanercept can be effective to maintain remission in ankylosing spondylitis patients

@article{Stefano2013LowDO,
  title={Low doses of etanercept can be effective to maintain remission in ankylosing spondylitis patients},
  author={Renato de Stefano and Elena R Frati and Davide De Quattro and Luana Menza and Stefania Manganelli},
  journal={Clinical Rheumatology},
  year={2013},
  volume={33},
  pages={707-711}
}
We wanted to do a prospective open-label study to evaluate if ankylosing spondylitis (AS) patients in clinical remission with twice weekly etanercept (ETN) 25 mg therapy could be changed to weekly regimen or even to every other week regimen without increased dose for injection. Thirty-eight AS patients self-administered 25 mg of ETN (Wyett) subcutaneously. According to the protocol, patients who were in clinical partial remission with twice weekly ETN 25 mg at week 12 and 16 changed to a weekly… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.
5 Citations
11 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 11 references

ASAS/ EURAL recommendations for the managementof ankylosing spondylitis

  • J Zochling, D van der Heijde, R Burgos-Vargas
  • Ann Rheum
  • 2006

Similar Papers

Loading similar papers…